30th Jul 2018 16:11
LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Monday that Spreadex Ltd held a 5.5% stake in the drug developer after a Tuesday transaction.
Through a combination of contracts for difference and ordinary shares, Spreadex's holding was 3.9 million shares. Its previous holding in Venn, if any, has not been disclosed.
Shares in Venn Life Sciences were down 1.2% at 6.18 pence on Monday.
Related Shares:
Venn Life Sciences